{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:33:11Z","timestamp":1782372791698,"version":"3.54.5"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>A 41-year-old woman with bone and liver metastasis of breast cancer was enrolled in our <jats:sup>68<\/jats:sup>Ga-labeled DOTA-ibandronic acid (<jats:sup>68<\/jats:sup>Ga-DOTA-IBA) PET\/CT tumor clinical trial. The examination revealed increased uptake of <jats:sup>68<\/jats:sup>Ga-DOTA-IBA in the multiple bone metastases. Unexpectedly, <jats:sup>68<\/jats:sup>Ga-DOTA-IBA uptake in meningioma and liver metastasis were also noted.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005890","type":"journal-article","created":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T15:02:47Z","timestamp":1747753367000},"page":"783-784","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["68Ga-DOTA-IBA Uptake in Meningioma and Liver Metastasis of Breast Cancer"],"prefix":"10.1097","volume":"50","author":[{"given":"Haoyuan","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqing","family":"Xuan","sequence":"additional","affiliation":[{"name":"Department of Ultrasound, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4088-7649","authenticated-orcid":false,"given":"Yue","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The Affiliated Hospital of Southwest Medical University"},{"name":"Nuclear Medicine and Molecular Imaging Key Laboratory of Sichuan Province"},{"name":"Institute of Nuclear Medicine, Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,5,20]]},"reference":[{"key":"R1-20250630","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/RLU.0000000000004757","article-title":"Biodistribution and internal dosimetry of 68Ga-DOTA-IBA PET imaging for patients with bone metastases","volume":"48","author":"Yang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R2-20250630","doi-asserted-by":"crossref","first-page":"1027792","DOI":"10.3389\/fonc.2022.1027792","article-title":"Preparation, biological characterization and preliminary human imaging studies of (68)Ga-DOTA-IBA","volume":"12","author":"Wang","year":"2022","journal-title":"Front Oncol"},{"key":"R3-20250630","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/RLU.0000000000004717","article-title":"177Lu-DOTA-IBA therapy in prostate cancer with bone metastases","volume":"48","author":"Li","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R4-20250630","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/RLU.0000000000004634","article-title":"Safety and efficacy of 68Ga- or 177Lu-labeled DOTA-IBA as a novel theranostic radiopharmaceutical for bone metastases: a phase 0\/I study","volume":"48","author":"Qiu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R5-20250630","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/RLU.0000000000005133","article-title":"68Ga-DOTA-ibandronic acid PET\/CT in a patient with chemotherapy-induced salivary gland hypofunction","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R6-20250630","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1097\/RLU.0000000000005415","article-title":"Incidental uptake of 68Ga-DOTA-IBA in prostate adenocarcinoma","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R7-20250630","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1097\/RLU.0000000000005200","article-title":"68Ga-DOTA-IBA uptake in breast cancer","volume":"49","author":"Xiang","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R8-20250630","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/RLU.0000000000005462","article-title":"Increased uptake of 68Ga-DOTA-IBA in multiple subcutaneous metastases of prostate cancer","volume":"49","author":"Liu","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R9-20250630","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1080\/09553002.2023.2242935","article-title":"Extraosseous distribution of (99m)Tc-diphosphonates during bone scintigraphy: review of the literature with case series presentation","volume":"100","author":"Conte","year":"2024","journal-title":"Int J Radiat Biol"},{"key":"R10-20250630","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12880-019-0345-1","article-title":"Accurate characterization of (99m)Tc-MDP uptake in extraosseous neoplasm mimicking bone metastasis on whole-body bone scan: contribution of SPECT\/CT","volume":"19","author":"Zhang","year":"2019","journal-title":"BMC Med Imaging"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005890","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:01:18Z","timestamp":1751299278000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,20]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005890","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,20]]},"assertion":[{"value":"2024-11-06","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}